Concepedia

Abhijit Chakraborty

AC

44

Publications

3.1K

Citations

29

H-Index

1998

Active since

Affiliations

Novartis (Switzerland)(Current)

University at Buffalo, State University of New York

Novartis Institutes for BioMedical Research

Novartis (United States)

University of Minnesota

Abhijit Chakraborty is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

1998–2025

44

Publications

44

Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia

Karen Thudium Mueller, Shannon L. Maude, David L. Porter et al. · Blood · 2017 · 348 citations · Full text

A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas

Jeffrey R. Infante, Philippe A. Cassier, John F. Gerecitano et al. · Clinical Cancer Research · 2016 · 315 citations · Full text

Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia

Karen Thudium Mueller, Edward Waldron, Stephan A. Grupp et al. · Clinical Cancer Research · 2018 · 218 citations · Full text

A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features

Nicolino Ruperto, Pierre Quartier, Nico Wulffraat et al. · Arthritis & Rheumatism · 2011 · 191 citations

Cancer Care Delivery Challenges Amidst Coronavirus Disease – 19 (COVID-19) Outbreak: Specific Precautions for Cancer Patients and Cancer Care Providers to Prevent Spread

Abhishek Shankar, Deepak Saini, Shubham Roy et al. · Asian Pacific Journal of Cancer Prevention · 2020 · 160 citations · Full text

Rows per page

1–5 of 44